QualityStocksNewsBreaks – Vivos Therapeutics Inc. (NASDAQ: VVOS) Establishes Clinical Advisory Board to Help Drive Growth
Vivos Therapeutics (NASDAQ: VVOS), a medical technology company focused on developing and commercializing innovative treatments for patients suffering from sleep-disordered breathing including obstructive sleep apnea (“OSA”), announced the creation of its new Clinical Advisory Board. The six-member board will focus on driving adoption and growth of Vivos’ next-gen treatments for OSA. Reports indicate that an estimated 1 billion people around the world struggle with OSA. Members of Vivos’ new board include the following: neurologist and sleep specialist Clete A. Kushida, MD, PhD; nationally recognized key opinion leader Edward Zuckerberg, DDS; co-founder of the American Academy of Physiological Medicine and Dentistry…